BLTE
UBS Group’s Belite Bio BLTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Buy |
2,358
+1,807
| +328% | +$104K | ﹤0.01% | 5733 |
|
|
2025
Q1 | $36.5K | Sell |
551
-11,656
| -95% | -$772K | ﹤0.01% | 6525 |
|
|
2024
Q4 | $770K | Buy |
12,207
+12,079
| +9,437% | +$762K | ﹤0.01% | 4409 |
|
|
2024
Q3 | $6K | Buy |
+128
| New | +$6K | ﹤0.01% | 6794 |
|
|
2024
Q1 | – | Sell |
-348
| Closed | -$15.9K | – | 8126 |
|
|
2023
Q4 | $15.9K | Sell |
348
-535
| -61% | -$24.5K | ﹤0.01% | 6032 |
|
|
2023
Q3 | $28.1K | Buy |
883
+583
| +194% | +$18.6K | ﹤0.01% | 5486 |
|
|
2023
Q2 | $4.29K | Buy |
300
+180
| +150% | +$2.57K | ﹤0.01% | 6468 |
|
|
2023
Q1 | $3.59K | Sell |
120
-4,097
| -97% | -$123K | ﹤0.01% | 7198 |
|
|
2022
Q4 | $127K | Buy |
+4,217
| New | +$127K | ﹤0.01% | 4767 |
|
|
2022
Q3 | – | Sell |
-683
| Closed | -$21K | – | 9213 |
|
|
2022
Q2 | $21K | Buy |
+683
| New | +$21K | ﹤0.01% | 5766 |
|